0000000000844206

AUTHOR

Thomas Similowski

showing 4 related works from this author

Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases

2017

We were very interested in the comments made by I. Cavedies and co-workers regarding our paper entitled “Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases” [1].

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsMEDLINE03 medical and health sciences0302 clinical medicineCorrespondenceotorhinolaryngologic diseasesmedicineHumansRespiratory systemAgorabusiness.industrySwallowing Disordersdigestive oral and skin physiologyCongresses as TopicRespiration DisordersEurope030228 respiratory system18Physical therapyRespiration Disordersmedicine.symptomDeglutition Disordersbusiness030217 neurology & neurosurgeryOropharyngeal dysphagiaEuropean Respiratory Journal
researchProduct

Non-invasive ventilation effectiveness and the effect of ventilatory mode on survival in ALS patients.

2013

Non-invasive ventilation (NIV) prolongs survival in amyotrophic lateral sclerosis (ALS), but there are no data with which to compare the effectiveness of the different ventilator modes – volume (Vol-NIV) or pressure-cycled (Pres-NIV) ventilation – in ALS. We aimed to determine whether the ventilatory mode has an effect on ventilation effectiveness and survival of ALS patients using NIV. We used a retrospective study that included all ALS patients for whom NIV was indicated in two referral units: one using Vol-NIV and the other using Pres-NIV. Demographic, functional and nocturnal gas exchange parameters at NIV initiation were recorded. Eighty-two ALS patients ventilated using Pres-NIV and 6…

MaleAnalysis of VarianceNoninvasive Ventilationbusiness.industryTreatment outcomeAmyotrophic Lateral SclerosisRetrospective cohort studyMiddle Agedmedicine.diseaseBulbar dysfunctionTreatment OutcomeNeurologyRespiratory failureAnesthesiaBreathingMedicineHumansFemaleNeurology (clinical)Amyotrophic lateral sclerosisbusinessRespiratory InsufficiencyAgedRetrospective StudiesAmyotrophic lateral sclerosisfrontotemporal degeneration
researchProduct

Should we use gait speed in COPD, FEV 1 in frailty and dyspnoea in both?

2016

Frailty is a progressive physiological decline in multiple organ systems marked by loss of function, loss of physiological reserve and increased vulnerability to disease [1]. Biological (inflammation and loss of hormones), clinical ( e.g. sarcopenia and osteoporosis) and social factors are involved in frailty onset, evolution and prognosis [2, 3]. Links between frailty, dyspnoea and chronic respiratory diseases represent a novel and practical approach

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV]Life Sciences [q-bio]OsteoporosisDiseaseIdoso FragilizadoDispneia03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicineForced Expiratory VolumemedicineHumans030212 general & internal medicineLoss functionOrgan systemComputingMilieux_MISCELLANEOUSAgedAged 80 and overCOPDFrailtybusiness.industrymedicine.disease3. Good healthGait speedWalking SpeedPreferred walking speedDyspnea030228 respiratory systemSarcopeniaPhysical therapyCardiologyDoença Pulmonar Obstrutiva CrónicaVolume Expiratório ForçadoAged; Aged 80 and over; Dyspnea; Forced Expiratory Volume; Frailty; Humans; Pulmonary Disease Chronic Obstructive; Walking Speed; Pulmonary and Respiratory MedicinebusinessHuman
researchProduct

Proceedings of Réanimation 2017, the French Intensive Care Society International Congress

2017

biologybusiness.industry030208 emergency & critical care medicineLymphocyte proliferationCritical Care and Intensive Care MedicineMeeting Abstractslaw.invention03 medical and health sciencesInterleukin 100302 clinical medicine030228 respiratory systemlawPD-L1ImmunologyPostoperative infectionCardiopulmonary bypassbiology.proteinMedicine030212 general & internal medicinebusinessAnnals of Intensive Care
researchProduct